Introduction
NK cells are crucial for innate host defense against certain tumor cells and pathogens, and in particular, against viral infections [1] . The susceptibility of tumor targets to natural killing is inversely related to target-cell expression of MHC class I molecules, which formed the basis for the "missing-self" hypothesis [2] . "Missing-self" is now explained by the expression of NK cell inhibitory receptors specific for MHC class I molecules [3, 4] . In humans, there are three distinct families of inhibitory receptors for HLA class I molecules: (1) killer cell Ig-like receptors (KIR), which are type I transmembrane molecules belonging to the immunoglobulin (Ig) superfamily [5] ; (2) immunoglobulin like transcripts (ILT), which are expressed mainly on B, T and myeloid cells, although some members are also expressed on NK cells [6] ; (3) killer cell lectin-like receptors (KLR), which are type II transmembrane glycoproteins encoded by the NK gene complex (NKC) [7] [8] [9] . Inhibitory receptors mediate their effects through the immunoreceptor tyrosine-based inhibitory motif/s (ITIM) present in their cytoplasmic domain [3] , which become/s tyrosine phosphorylated by a src-family tyrosine kinase on ligand binding. The src-family tyrosine kinases include SH2-domain-containing protein tyrosine phosphatase 1 (SHP-1), SHP-2 and SH2-domain-containing inositol polyphosphate 5' phosphatase (SHIP1). SHP-1, in particular, has been demonstrated to associate with phosphorylated ITIMs, and to mediate inhibition of NK cell cytotoxicity.
Several different NKC-encoded KLR families have thus far been identified; members are generally activating, inhibitory or co-stimulatory receptors. With the exception of NKG2 (natural killer group 2), most KLRs are orphan receptors, whose physiological ligands and/or functions remain undefined or have not been directly determined. The human NKG2A-CD94 (KLRC1) and NKG2C-CD94 (KLRC2) heterodimers recognize the non-classical MHC class I molecule, HLA-E (Qa-1 in mice), which primarily displays peptides derived from the signal peptides of classical MHC class I molecules [10] . The interactions of NKG2-CD94 heterodimers with HLA-E or Qa-1 molecules allow NK cells to indirectly monitor the expression of classical MHC class I molecules. Human and mouse KLRs orthologues have a broad expression pattern, which includes both NK and T cell subsets [11] . NKG2A-CD94
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this is responsible for down-regulating their antigen-specific cytotoxicity during both viral clearance and virus-induced oncogenesis [12] . CD94/NKG2 expression is also observed on Ag-specific CD8 + T cells following infection with influenza virus and Listeria monocytogenes, but in these infections binding of the CD94/NKG2A receptor by its ligand (Qa-1b) does not significantly inhibit CD8 + T cells. CD94/NKG2A-mediated inhibition of T cells may thus be limited to particular circumstances or may involve synergy with other receptors that are similarly up-regulated. [13, 14] . NKG2D (KLRK1) molecules are also expressed by T cells, mediating co-stimulatory functions dependent on the availability of the adaptor protein DAP10 [15] , and emerging data also indicate that primed T cells might express other NKC molecules, including the Ly49 family and KLRG1 [16, 17] . However, the role of these molecules in modulating the function of antigen-specific T cells requires further evaluation.
In this study, we report the molecular cloning, tissue and cell distribution, chromosome arrangement and functional analysis of a novel NK cell receptor, KLRL1, derived from human or mouse dendritic cells. The predicted protein is a type II transmembrane protein which contains an ITIM in the cytoplasmic tail, and belongs to the KLR family. We demonstrate that KLRL1 associates with the tyrosine phosphatases SHP-1 and SHP-2, and inhibits NK cell cytotoxicity.
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Materials and methods

Cell culture
Unless stated otherwise, cell lines were obtained from ATCC and maintained in RPMI 1640 medium (Invitrogen, Carlsbad, CA) supplemented with 2 mM glutamine, penicillin (100 U/ml), streptomycin (100µg/ml), and 10 % (v/v) heat-inactivated fetal calf serum (FCS, Hyclone, Logan, UT) in a 37°C 5 % CO 2 atmosphere. The NK-92 cell line, kindly gifted by 
Cloning of human and mouse KLRL1 full-length cDNA
The main EST of human KLRL1 (hKLRL1) was directly isolated from a human dendritic cells (DC) cDNA library by large-scale random sequencing as described previously [18, 19] . Full-length cDNA was cloned from human DC using the PCR primers 
Cellular and tissue distribution of human and mouse KLRL1
Total cellular RNA was isolated using Trizol reagent (Invitrogen), and first strand cDNA prepared using the Superscript II system with an Oligo(dT) 15 primer (Invitrogen).
cDNA synthesis was checked by PCR, with human or mouse -actin primers as a positive control. Human adult multiple tissue cDNA (MTC) panels were purchased from Clontech.
RT-PCR was performed with primers specific for hKLRL1 and mKLRL1 as described above.
The reaction was subjected to denaturation (94°C for 30 sec), annealing (55°C for 30 sec), and extension (72°C for 30 sec) for 30 cycles and PCR products confirmed by DNA sequencing.
Eukaryotic expression vector construction and cell transfection
To express Flag-tagged hKLRL1 and mKLRL1 proteins (hKLRL1-Flag and Spleen cells were fused with murine SP2/0 myeloma cells using polyethylene glycol-1000 and cultured in 96-well plates using standard procedures. Hybridoma supernatants were screened for their reactivity against hKLRL1-Flag fusion protein by ELISA. Selected hybridomas were cloned by limiting dilution, and mAbs were produced in ascites fluids and were added and precipitation performed for 8 hrs at 4°C. The beads were washed three times with 0.5% digitonin lysis buffer and centrifuged for 3 min at 2,300g, resuspended in SDS sample buffer, and boiled for 2 min. Samples were run on SDS-PAGE, transferred to PVDF membranes, and analyzed as described above.
Fluorescence confocal microscopy analysis
293T cells and L929 cells growing on glass coverslips placed in 6-well plates were transiently transfected with KLRL1/GFP expression vectors. 48 hrs after transfection, cells were observed by fluorescence confocal microscopy.
N-Glycoside F digestion
10ዊ10
6 293T cells transiently transfected with phKLRL1/Flag expression vector were lysed in 10 mM sodium phosphate buffer, pH6.5, containing 0.1% SDS, and 50 mM -mercaptoethanol. To denature the proteins, the cell lysates were heated for 5 min at 95°C, and then Nonidet P-40 (final concentration, 1%), and protease inhibitor mixture (Sigma)
were added. Aliquots of these preparations were treated with N-glycosidase F (5 mU/ml, Calbiochem, Darmstadt, Germany) for 8 hrs at 37°C. Reactions were stopped by the addition of SDS-PAGE loading buffer, and samples subjected to Western blot analysis as described above.
Expression and purification of soluble hKLRL1-Fc fusion protein
Coding regions of human interleukin-2 signal peptide, the extracellular domain (residues 133-265) of hKLRL1 and human IgG4 CH2 and CH3 fragments were cloned in frame into pcDNA3.1/mic-His (-) B for expression of secreted human extracellular KLRL1-Fc fusion protein (hexKLRL1-Fc). COS-7 cells were transfected using the DEAE-dextran method with minor modifications. After overnight recovery in DMEM supplemented with 10% FCS, cells were cultured in DMEM plus 1%FCS for 6 days [20] .
The supernatant was harvested and secreted hexKLRL1-Fc protein purified using Affi-Gel protein A-agarose columns (Bio-Rad, Hercules, CA).
Flow Cytometry
For single-color analysis, 50 µl of cells (10ዊ10 6 cells/ml) were incubated with 5 µl 
Cytolytic assay
Cytolytic activity of NK cells was measured with the CytoTox 96 Non-Radioactive
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Results
Identification and sequence analysis of human and mouse KLRL1
An EST for a potential novel C-type lectin protein was originally identified by large-scale random sequencing [18, 19] , and full-length cDNA was obtained by PCR from human dendritic cells ( of receptors. The overall protein sequence showed 34% identity and 51% similarity with hCLEC1 (human C-type lectin-like receptor 1), 30% identity and 47% similarity with hCLEC2, 29% identity and 43% similarity with hLOX1 (endothelial receptor for oxidized low density lipoprotein) and 24% identity and 43% similarity with hCD94 (Fig.1B) .
Sequence comparisons showed that it belongs to the KLRs, but constitutes the first member of a separate, novel family (family L) and it was thus designated human Killer cell C-type Lectin-like Receptor L 1 (hKLRL1, Fig.1C ). The full-length sequence is available in GenBank under the accession number AF247788.
Blast searches of a mouse EST database (GenBank dbEST) using the predicted polypeptide sequence of hKLRL1 lead to the cloning of a mouse homologue of hKLRL1, designated mKLRL1 (accession no. NM_177686). The 2181-bp full-length cDNA, obtained from mouse DC, encoded a 267-residue type II transmembrane protein with a typical C-type For personal use only. on March 30, 2017 . by guest www.bloodjournal.org From lectin domain, with features similar to those of hKLRL1, including four potential N-glycosylation sites. Overall, human and mouse KLRL1 shared 50% identity and 65% similarity (Fig.1A) . A rat orthologue of KLRL1 (rKLRL1, accession no. XM_232420), identified from rat EST databases, shared 70% similarity with hKLRL1 and 86% with mKLRL1.
KLRL1 Possesses Structural Features Characteristic of the KLR Family
The predicted hKLRL1 protein consisted of four structural regions: cytoplasmic (residues 1-43), transmembrane (44-66), stalk (67-132), and a C-type lectin-like domain (CTLD; 133-265), a key feature of the KLR family. Many other structural features of KLR subfamily receptors were present in hKLRL1. All KLR subfamily receptors contain CTLD motifs and thus structurally belong to the C-type lectin family. 13 invariant residues (including 6 Cys, which play a crucial role in forming disulfide bridge frameworks) are relatively conserved among CTLD sequences of different C-type lectins [23] . A putative CTLD motif (133 -249), in the C-terminal region of hKLRL1, contains 11 out of the 13 invariant residues, including all the 6 Cys residues (Fig.1B) . CTLD homology was compared with those of other KLRs. The CTLD of hKLRL1 was most similar to those of human CD94 (29% similarity and 42% identity) and human LOX-1 (26% similarity and 31% identity) (Fig.1 B) . In common with other KLRs, the CTLDs of human and mouse KLRL1 lack the motifs required for Ca 2+ binding and showed little sequence similarity to the ligand-binding loops of classical C-type lectins. Of note, a putative immunoreceptor tyrosine-based inhibitory motif (ITIM) [24] [25] [26] was identified close to the N-terminus of the cytoplasmic domain of both hKLRL1 and mKLRL1 (VTYADL and IVYANL, respectively, conserved amino acids underlined, Fig.1 A) . The structural features characteristic of KLRs present in KLRL1 suggested that KLRL1 might function as a killer cell receptor, with its actions mediated by interactions with other signaling molecules.
For is now recognized as a region that is particularly enriched for genes encoding C-type lectin-like receptors important for NK cell functions, and this region has been designated NK gene complex. These receptors are all involved in activating, inhibitory or co-stimulatory signaling functions in immune cells. Similar conservation of KLRL1 gene location was observed for mouse and rat: mKLRL1 and rKLRL1 genes were located within the NK gene complex on mouse and rat chromosomes 6F3 (Fig. 2B ) and 4q42(data not shown), respectively, accompanied by Klrg1 [32] , C lectin-related protein A (ClrA) [33] , CD69, Clec2, Clecsf12, LOX-1, KLRE1 [34] , D1, C3, C2, C1 and ly49 [35] . The location of the KLRL1 gene in the KLR family gene cluster indicated that there might have been multiple gene duplications within the KLR family during its evolution from a common ancestral gene. 
KLRL1 is preferentially expressed in lymphoid tissues and immune cells
In human multiple tissue cDNA panels, hKLRL1 mRNA was highly expressed in lymphoid tissues such as spleen and peripheral blood leukocytes, and present at lower levels in thymus, placenta, pancreas and small intestine (Fig. 3A) . Expression was not detected in heart, brain, lung, liver, skeletal muscle, kidney, prostate, testis, ovary or colon. A similar expression pattern was observed for murine KLRL1, with mKLRL1 mRNA preferentially expressed in peripheral blood leukocytes, less frequent in thymus, spleen, heart, brain and lung, and undetectable in other tissues (Fig. 3B) (Fig 4A) , and no specific band was observed in mock vector transfected cells. The apparent molecular mass was considerably larger than that predicted from the deduced amino acid sequence (30.8 kDa), suggesting that hKLRL1-Flag protein was very likely to be modified after its translation.
Glycosylation was the most likely post-translational modification, as hKLRL1 contained six putative N-glycosylation sites within the stalk and C-type lectin domains. To confirm the glycosylation of hKLRL1, we treated the cell lysate of phKLRL1/Flag-transfected 293T cells with peptide N-glycosidase F. As shown in Fig. 4A , the apparent molecular mass of the N-glycosidase F-treated hKLRL1-Flag protein was reduced to about 31 kDa, consistent with the calculated molecular mass of hKLRL1, indicating that mature hKLRL1 protein is highly glycosylated.
Since human KLRL1 was predicted to be a type II transmembrane protein, we examined the cellular localization of GFP-fused KLRL1 to determine whether it localized to the cell surface. phKLRL1/GFP and pmKLRL1/GFP expression vectors were transiently transfected into 293T and L929 cells, respectively. 48 hrs after transfection, cells were subjected to fluorescence confocal microscopy analysis. As shown in Fig. 4B , specific signals of both GFP-fused hKLRL1 and mKLRL1 were restricted to the cell membrane, whereas the control GFP signal was diffused throughout the cytoplasm. This result confirmed the structural prediction that KLRL1 was a cell membrane-associated protein. [28] , CLEC1, CLEC2 [30] , DCAL1 (dendritic cell-associated lectin-1) [36] , KLRG1 [27] , KLRF1 [29] , CD94 and the NKG2 family; in rodents, the NKC contains Clr [33] , Klrg1 [32] , Klre1 [34] , Cd69, Cd94 and Ly49 family members [35] . The KLRL1 protein is a CTLD-containing type II transmembrane glycoprotein; it is most closely related to CLEC1 and CD94, and shares modest similarity with all known members of the KLR family. The conservation in sequence, structure and chromosome arrangement is reminiscent of the leukocyte receptor complex on chromosome 19q13.3-13.4, which includes the killer cell Ig-like receptors (KIR) expressed on NK cells and subsets of T cells, the gp49 family of receptors expressed on mast cells and natural killer cells, and sialic acid-binding Ig-like lectins (Siglec-3, -5, -6, -7, -8, -9 and -10) expressed on myeloid cells and DCs [19] .
This suggests structural and functional co-evolution of these receptors on NK, myeloid and dendritic cells. The stalk section of the hKLRL1 molecule contains two conserved cysteines that have been shown to form disulphide-linked dimers [37, 38] . We would therefore expect that native hKLRL1 also formed homodimers or heterodimers in cells, as is the case with the other KLRs. However, species of ~75 kDa in hKLRL1/Flag transfected cell lysates, although much larger than the molecular size predicted from the amino acid sequence, was observed under both non-reducing and reducing conditions. Given that N-Glycoside F treatment reduces the apparent molecular mass to about 31 kDa, consistent with the calculated molecular mass of hKLRL1, high levels of glycosylation, rather than dimerization, appear to be responsible for the high molecular weight of the mature hKLRL1 protein. colleagues reported a novel inhibitory C-type lectin-like receptor, designated MICL and identical to KLRL1, which negatively regulates granulocyte and monocyte function [39] .
Among the KLRs, NKG2A contains two functional ITIMs that recruit both SHP-1 and SHP-2, but not SHIP, via their SH2 domains [40] ; and NKG2F (KLRC4) also has both a cytoplasmic ITIM-like sequence and a charged transmembrane amino acid residue but its exact function is not known. We prepared an hKLRL1-Fc fusion protein and used it to investigate the role of hKLRL1 in NK cell cytotoxicity. We demonstrated that blocking of potential hKLRL1 ligands on target cells enhanced NK cell cytotoxicity, further supporting the notion that hKLRL1 functions as an inhibitory receptor of NK cells.
Flow cytometry with hKLRL1-Fc fusion protein showed that the putative ligand(s) of CRDs known to bind mannose or glucose derivatives, and is present in two domains of the macrophage-mannose receptor (MMR) [41] . The EPS sequence present in the CRD-2 of the MMR is believed to contribute only weakly to binding of polyvalent ligands [42] . In contrast, the sequence QPD is characteristic of CRDs that bind galactose and N-acetyl-galactosamine and is present in the hepatic ASGPR-1 and -2 [41] . However, these sequences are lacking from the amino acid sequences of both hKLRL1 and mKLRL1. Further studies are required to confirm whether the nonclassical MHC class I molecules are the natural ligands of KLRL1, since most KLRs are receptors for nonclassical MHC class I molecules [10, 32, 43] . shown that blockade of inhibitory receptors can effectively augment the antitumor activity of both allogeneic and syngeneic NK cells, which may be an improved strategy for NK cell-based immunotherapy [44] [45] [46] .
In conclusion, we have identified a novel C-type lectin-like molecule, KLRL1, which has preferential hematopoietic expression and acts as a NK cell inhibitory receptor. Future studies are required to elucidate the physiological functions of this receptor and to discover its putative heterodimeric partner molecule and naturally-recognized ligands. 
